CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. - Wikidata - wikimedia - TriplyDB

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

http://www.wikidata.org/entity/Q37165792

about

"Attack of the Clones": Commonalities Between Cancer and Atherosclerosis.The role of necroptosis in atherosclerotic disease.Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosis.The Role of Efferocytosis in Atherosclerosis.A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.Cysteine proteases in atherosclerosis.Unifying mechanism for different fibrotic diseases.The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.The walking dead: macrophage inflammation and death in atherosclerosis.Macrophages in vascular inflammation and atherosclerosis.Eating the Dead to Keep Atherosclerosis at Bay.Specialized pro-resolving mediators in cardiovascular diseases.Monocytes and macrophages in abdominal aortic aneurysm.Cell Death in the Vessel Wall: The Good, the Bad, the Ugly.Bone Marrow Takes Center Stage in Cardiovascular Disease MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.Heart disease: Death-defying plaque cells.Acute CD47 Blockade During Ischemic Myocardial Reperfusion Enhances Phagocytosis-Associated Cardiac Repair Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages.Reconciling Smooth Muscle Cell Oligoclonality and Proliferative Capacity in Experimental Atherosclerosis.Efferocytosis and Outside-In Signaling by Cardiac Phagocytes. Links to Repair, Cellular Programming, and Intercellular Crosstalk in Heart.Recent Advances in Managing Atherosclerosis via Nanomedicine.Monocyte-Macrophages and T Cells in Atherosclerosis.CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.Mitochondrial Fission Promotes the Continued Clearance of Apoptotic Cells by Macrophages.2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis.Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis.Too much of a good thing: How modulating LTB4 actions restore host defense in homeostasis or disease.Fluorogenic 2D Peptidosheet Unravels CD47 as a Potential Biomarker for Profiling Hepatocellular Carcinoma and Cholangiocarcinoma Tissues.Cardiovascular disease: Reactivating cellular rubbish removal ameliorates atherosclerosis.Macrophage polarization and acceleration of atherosclerotic plaques in a swine model.CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT.Proefferocytic Therapy Promotes Transforming Growth Factor-β Signaling and Prevents Aneurysm Formation.Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag-/- Mice.Translating GWAS Findings to Novel Therapeutic Targets for Coronary Artery Disease.Human Gingiva-Derived Mesenchymal Stem Cells Modulate Monocytes/Macrophages and Alleviate Atherosclerosis.

P2860

Q30274746-56291E79-5C09-4553-AC9B-07D34F902BD7 Q33643471-6F339070-BDE2-4AFA-9FCD-FA154EA96C5D Q33764821-A2AFDAC1-3C9C-44B7-BDF3-9A13228D3418 Q34549423-6D99D86B-EC54-48EF-9DE5-F50E18976648 Q34680660-D0726D85-BB5C-4C0A-89AE-0C23CD8D2E00 Q37739218-9CE7A009-AD9F-402C-87EF-7FFAAECB9411 Q38681468-4D4CD9C0-4EEB-4273-99F7-1A1BFE849062 Q38756684-79EEBB48-D300-448D-B150-5EA8565D531D Q38829704-9FA591A6-BAA1-44A2-9D75-E1D7ABBED082 Q38930113-3D2A9527-D921-4A09-88BB-C5009015B51D Q39109119-D9EAEA80-F821-4804-AE1A-BE283FA159B8 Q39123553-88446828-710C-4677-AB24-17E4D5C45792 Q39134393-89A1DB40-E258-49C5-9C15-BDBBEBBF8566 Q39160278-D20CEA34-00BE-4E7B-84EE-8F2ED2739A55 Q39239967-201C3211-CE73-489E-B0C4-4DD78DAB54A0 Q39388843-9088EAAF-2513-4E42-901B-A13E245A49E7 Q41021142-6D7987CA-3454-4033-AA88-38F8F2C5FBC9 Q42001768-B0A91053-DD5C-4CA0-A952-5CA28EDB1A51 Q42173660-95F3F2E0-2B76-4884-AE35-8EC7A6548D94 Q42357842-4950933B-5D7E-42BB-98E4-E29250A50F79 Q42358931-DFA1BA3C-7AED-458D-A633-610FB314A669 Q42374930-74FE8737-B11E-4389-8EA2-93E6DF26835A Q45048571-EB81560A-6C8A-4780-9852-88C9A082A0D5 Q45341410-5EB9F0FF-78DB-4465-A0EC-D0A7979C2C75 Q47251361-9F576B45-9D4F-4D2B-ACBA-25F28AA94F43 Q47632654-A94B80D2-36AF-4A79-AC4D-E4FB61DAD3AE Q47708298-17345823-98BA-457E-A014-F32B1B366E09 Q47752734-62539DFD-B8BB-4710-A005-56F1E1B44EBB Q48507796-6E4B8220-EC16-4AF3-83D7-E408B5DA7E08 Q49318594-C15B30AA-3629-479E-A59E-B035213EFBD0 Q49691927-4BC01D30-EA34-4F0D-B0EF-C8434F83DB78 Q50084722-DFA8E088-22C8-42D1-BFA7-CAB703BCDC80 Q51095953-EABDD3E0-DF8E-45AE-A957-175B3F086DD9 Q51563435-DB3CBF31-1C93-479B-B0C4-07EA040AAC0E Q51760968-6C1C069F-F2A9-4B42-A9F2-1A6164FB8658 Q52597558-2B650B89-CBC9-41F5-9924-F7645E1B1433 Q52732113-BE06BF2A-97BF-4EB9-B849-2548E13E6177 Q54213057-ABB84A83-1470-4AFD-BB7C-7AE6C7DB16B8 Q55175982-97AE9B33-C4EF-4C63-A30F-41A86F0BB53B Q55275182-B5262F7C-6689-4482-A571-2B95C1B31545

P2860

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

http://www.wikidata.org/entity/Q37165792

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

@en

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

@nl

type

label

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

@en

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

@nl

prefLabel

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

@en

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

@nl

P1433

Q37165792-AF8AF3B6-5A77-4C9D-9733-F94AA985E7D4

P1476

Q37165792-7A0AE9C5-CB94-4078-931A-AFC8F910F6F0

P2093

Q37165792-15F03D2F-F91D-48A4-9388-AC72B7EAE64C

Q37165792-1FAE2C45-247F-4D40-AD51-A6FDEEB7D597

Q37165792-26790824-1653-42C0-BEC4-7130A713C929

Q37165792-61A886A2-8B89-4D6E-9212-C4C3E93004DC

Q37165792-6BD72CBC-91F5-48E4-B840-4439908FBC57

Q37165792-8219FAE9-0CA8-47E4-B2AC-783A9DE55CFC

Q37165792-8871590C-B82B-42C1-990D-C8D78D02DBD4

Q37165792-A5C2804D-A864-4B1A-816C-9AC7C2A7E987

Q37165792-B6CBE82E-208C-489C-9599-08077A5308FD

Q37165792-C34E1FFE-E5EC-43AF-B6AD-F78B34E03A00

P2860

Q37165792-09C8163B-620B-4C07-8E4C-CF33A013265F

Q37165792-13B027F3-4357-44CF-80EF-02AB77AC6D64

Q37165792-19917C95-8B75-4F2D-8CA7-54DDC9A31C44

Q37165792-1BCBDAD0-22D9-43B2-ACE9-094A186337EC

Q37165792-1CB4B0B9-8941-4F0E-9D26-1EC35353D8AD

Q37165792-1FA58108-1B74-4369-9531-1819A2247A5E

Q37165792-29B1BD28-0097-4AB3-BEBB-DFD2B30EF5AD

Q37165792-2B17A97F-398F-4027-8B54-3B929729201F

Q37165792-2C1774BE-F6D6-4106-B0D6-C5B153D33CDB

Q37165792-2E4E7B2F-BEB8-4759-8E8F-21E631A0E1BB

P2888

Q37165792-1882485F-4425-49E3-9DAB-A8DC73BD3CE9

P304

Q37165792-5E5C3F4F-8BA1-4D59-9505-E111B518C0B7

P31

Q37165792-B80CDCA7-6293-42FE-B3BC-C64D26F10D6C

P356

Q37165792-CE99ACF3-9B73-4604-A674-1A3F79501001

P407

Q37165792-E49E9963-C9E9-470E-884D-18985709F22B

P433

Q37165792-FDC90D46-DA2C-4DC5-B444-70A39767DE5E

P478

Q37165792-F4BDAD25-6FBB-49D2-9E70-82CA79315706

P50

Q37165792-3C9DCFEB-DCEC-4A49-BB17-C6A977EC3A2E

Q37165792-9348C440-6E11-4CA8-A27E-62AB20B30C65

Q37165792-9F0EE0B8-A042-4D23-B333-6903D8BF93E2

Q37165792-A24579F1-3A70-4786-A48D-A27035089C04

P577

Q37165792-B6B4D997-65B5-4D2F-B9AA-0CD037FD732D

P698

Q37165792-1C08E6E7-2227-4A9F-9D3D-FA8EF03CF0AD

P921

Q37165792-2DB27A15-9CBD-4AD3-B3BC-1D6027984502

Q37165792-9CEC1E46-C145-4189-A843-CF653C9A585B

Q37165792-DE2D46F3-5E6E-4726-9F08-2D9F42B15CEA

P932

Q37165792-70AA93C9-1361-4F21-9A8C-DF9D54429F27

P356

P1433

P1476

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.

@en

P2093

Aldons Jake Lusis

http://www.w3.org/2001/XMLSchema#string

Andrew J Connolly

http://www.w3.org/2001/XMLSchema#string

Clint L Miller

http://www.w3.org/2001/XMLSchema#string

Daniel Direnzo

http://www.w3.org/2001/XMLSchema#string

Eric E Schadt

http://www.w3.org/2001/XMLSchema#string

Irving L Weissman

http://www.w3.org/2001/XMLSchema#string

Jens-Peter Volkmer

http://www.w3.org/2001/XMLSchema#string

Jianqin Ye

http://www.w3.org/2001/XMLSchema#string

Kelly McKenna

http://www.w3.org/2001/XMLSchema#string

Ljubica Perisic Matic

http://www.w3.org/2001/XMLSchema#string

P2860

Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

A common allele on chromosome 9 associated with coronary heart disease

Role of CD47 as a marker of self on red blood cells

CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1

Inflammation in atherosclerosis

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

Progress and challenges in translating the biology of atherosclerosis

KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.

P2888

P304

86-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE18935

http://www.w3.org/2001/XMLSchema#string

P407

P433

7614

http://www.w3.org/2001/XMLSchema#string

P478

536

http://www.w3.org/2001/XMLSchema#string

P50

Lars Maegdefessel

P577

2016-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27437576

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4980260

http://www.w3.org/2001/XMLSchema#string